CG Results Healthcare advises Hospira, a Pfizer company, on the divestment of its UK compounding business to Baxter
- Service: Divestments
- Sector: Healthcare
- Sub Sector: Pharma & Biotech
- Engagement Type: Sell Side
We are delighted to announce that CG Results Healthcare, part of the Results International Group, has acted as exclusive financial advisor to Pfizer on the divestment of Hospira’s UK compounding business to Baxter.
This transaction reinforces our expertise in pharmaceutical divestments.
Hospira, the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, became part of Pfizer in 2015. CG Results Healthcare assisted Pfizer to focus on their strategic priorities by divesting the Hospira UK aseptic compounding business.
This transaction follows approval being granted by the Competition and Markets Authority.
Terms of the agreement were not disclosed.